Maryam Zamanian, MD
NPI 1174508311ActiveIndividual· Internal Medicine, Endocrinology, Diabetes & Metabolism· Dallas, TX
Internal Medicine, Endocrinology, Diabetes & Metabolism (MD) in Dallas, Texas, trained at University of Texas Southwestern Medical School at Dallas (class of 2002). Their prescriptions cost Medicare Part D more than their services did: $966,268 for 1,751 claims, against $42,545 paid for services in 2024. Madrigal Pharmaceuticals was the largest of 20 companies reporting payments in 2025, $977.09 in all, mostly food and beverage.
Overview
| NPI | 1174508311 |
|---|---|
| Status | Active |
| Entity type | Individual |
| Credential | MD |
| Sole proprietor | No |
| NPI issued | Dec 9, 2005 |
| Last updated in NPPES | Oct 28, 2011 |
Specialties and licenses
| Taxonomy | Code | License | State |
|---|---|---|---|
| Internal Medicine, Endocrinology, Diabetes & Metabolism Primary | 207RE0101X | M0612 | TX |
| Internal Medicine | 207R00000X | M0612 | TX |
Exclusion screening
| List | Result | Details |
|---|---|---|
| HHS-OIG LEIE · Nov 10, 2026 | No match | Checked by NPI and by name + state |
| North Carolina Medicaid · Nov 11, 2026 | No match | — |
| New York OMIG · Nov 11, 2026 | No match | — |
| Ohio Medicaid · Nov 11, 2026 | No match | — |
| Pennsylvania Medicheck · Nov 11, 2026 | No match | — |
| Washington HCA · Nov 11, 2026 | No match | — |
Official OIG search · How matching works ·Bulk check a roster
Medicare
| Enrollment (PECOS) | Enrolled Practitioner - Endocrinology (TX) |
|---|---|
| Accepts assignment | Yes (participating) |
Medicare services in 2024
| Medicare patients | 137 |
|---|---|
| Services billed | 601 across 13 procedure codes |
| Paid by Medicare | $42,545 |
Part D prescriptions in 2024
| Prescriptions (claims) | 1,751 · 4,069 30-day fills |
|---|---|
| Patients | 222 |
| Total drug cost | $966,268 |
| Generic share | 42% of claims |
Education and affiliations
| Medical school | University of Texas Southwestern Medical School at Dallas |
|---|---|
| Graduation year | 2002 |
| Medicare specialty | Endocrinology |
| Secondary specialties | Internal Medicine |
| Telehealth | Offers telehealth |
Hospital affiliation
- Medical City PlanoPlano, TX
Industry payments (Open Payments)
- 2025$977.09 · 50 payments from 20 companies
- 2024$861.92 · 52 payments from 12 companies
Top paying companies in 2025
| Company | Amount | Payments |
|---|---|---|
| Madrigal Pharmaceuticals | $172.21 | 8 |
| Lilly USA, LLC | $110.65 | 6 |
| Novo Nordisk Inc | $98.16 | 4 |
| Xeris Pharmaceuticals, Inc. | $93.81 | 5 |
| Abbvie Inc. | $65.05 | 3 |
What the 2025 payments were for
- Food and Beverage$977.09 · 50 payments
Receiving payments does not imply wrongdoing. What Open Payments covers ·original records
Other endocrinologists in Dallas
- 1033349642
- 1053529099
- 1093072548
- 1144428319
- 1174815245
- 1184856759
- 1194820266
- 1215060876
- 1225551781
- 1245432582
- 1245791854
- 1306265509
All 102 endocrinologists in Dallas · All endocrinologists in Texas